These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 15356787)
1. Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. Miró O; López S; Martínez E; Pedrol E; Milinkovic A; Deig E; Garrabou G; Casademont J; Gatell JM; Cardellach F Clin Infect Dis; 2004 Sep; 39(5):710-6. PubMed ID: 15356787 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy. Miró O; López S; Pedrol E; Rodríguez-Santiago B; Martínez E; Soler A; Milinkovic A; Casademont J; Nunes V; Gatell JM; Cardellach F Antivir Ther; 2003 Aug; 8(4):333-8. PubMed ID: 14526764 [TBL] [Abstract][Full Text] [Related]
3. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy. Miura T; Goto M; Hosoya N; Odawara T; Kitamura Y; Nakamura T; Iwamoto A J Med Virol; 2003 Aug; 70(4):497-505. PubMed ID: 12794710 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients. Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828 [TBL] [Abstract][Full Text] [Related]
6. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells. Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160 [TBL] [Abstract][Full Text] [Related]
7. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients. Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy. Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179 [TBL] [Abstract][Full Text] [Related]
10. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy. Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study. Rabing Christensen E; Stegger M; Jensen-Fangel S; Laursen AL; Ostergaard L Clin Infect Dis; 2004 Nov; 39(9):1371-9. PubMed ID: 15494915 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals. Gerschenson M; Shiramizu B; LiButti DE; Shikuma CM Antivir Ther; 2005; 10 Suppl 2():M83-9. PubMed ID: 16152709 [TBL] [Abstract][Full Text] [Related]
13. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment. Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688 [TBL] [Abstract][Full Text] [Related]
14. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activation. Casula M; Vrisekoop N; Wit FW; de Baar MP; de Ronde A; Miedema F; Reiss P J Infect Dis; 2007 Aug; 196(3):371-6. PubMed ID: 17597451 [TBL] [Abstract][Full Text] [Related]
16. Infection with HIV-1 induces a decrease in mtDNA. Casula M; Bosboom-Dobbelaer I; Smolders K; Otto S; Bakker M; de Baar MP; Reiss P; de Ronde A J Infect Dis; 2005 May; 191(9):1468-71. PubMed ID: 15809905 [TBL] [Abstract][Full Text] [Related]
17. Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function. Rosso R; Nasi M; Di Biagio A; Repetto E; Dentone C; Pinti M; Nemes E; Ferraresi R; Mussini C; Esposito R; Viscoli C; Cossarizza A Pediatr Infect Dis J; 2008 Jan; 27(1):17-21. PubMed ID: 18162932 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA depletion in HIV-infected patients is more pronounced with chronic hepatitis C and enhanced following treatment with pegylated interferon plus ribavirin. de Mendoza C; Sánchez-Conde M; Timmermans E; Buitelaar M; de Baar MP; Gonzalez-Lahoz J; Soriano V Antivir Ther; 2005; 10(4):557-61. PubMed ID: 16038482 [TBL] [Abstract][Full Text] [Related]
19. Platelets, a typical source of error in real-time PCR quantification of mitochondrial DNA content in human peripheral blood cells. Banas B; Kost BP; Goebel FD Eur J Med Res; 2004 Aug; 9(8):371-7. PubMed ID: 15337626 [TBL] [Abstract][Full Text] [Related]
20. In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis. Miró O; Villarroya J; Garrabou G; López S; Rodríguez de la Concepción M; Pedrol E; Martínez E; Giralt M; Gatell JM; Cardellach F; Casademont J; Villarroya F Antivir Ther; 2005; 10(8):945-51. PubMed ID: 16430200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]